دورية أكاديمية
Role of selective digestive decontamination in the prevention of VAP in COVID-19 patients: a pre-post observational study.
| العنوان: | Role of selective digestive decontamination in the prevention of VAP in COVID-19 patients: a pre-post observational study. |
|---|---|
| المؤلفون: | Biagioni Emanuela, Ferrari Elena, Gatto Ilenia, Serio Lucia, Farinelli Carlotta, Coloretti Irene, Talamonti Marta, Tosi Martina, Meschiari Marianna, Tonelli Roberto, Venturelli Claudia, Mussini Cristina, Clini Enrico, Sarti Mario, Cossarizza Andrea, Busani Stefano, Girardis Massimo. |
| المساهمون: | Biagioni, Emanuela, Ferrari, Elena, Gatto, Ilenia, Serio, Lucia, Farinelli, Carlotta, Coloretti, Irene, Talamonti, Marta, Tosi, Martina, Meschiari, Marianna, Tonelli, Roberto, Venturelli, Claudia, Mussini, Cristina, Clini, Enrico, Sarti, Mario, Cossarizza, Andrea, Busani, Stefano, Girardis, Massimo. |
| سنة النشر: | 2023 |
| المجموعة: | Archivio della ricerca dell'Università di Modena e Reggio Emilia (Unimore: IRIS) |
| مصطلحات موضوعية: | COVID19, Acute Respiratory Distress Syndrome, Intensive Care Unit, Mechanical Ventilation, treatment |
| الوصف: | The aim of our study was to evaluate whether the introduction of SDD in a structured protocol for VAP prevention was effective in reducing the occurrence of ventilator associated pneumonia (VAP) in COVID19 patients without changes in the microbiological pattern of antibiotic resistances. This observational pre-post study including adult patients requiring invasive mechanical ventilation (IMV) for severe respiratory failure related to SARS-CoV-2 admitted in three COVID19 intensive care units (ICUs) in an Italian hospital from February 22, 2020, to March 8, 2022. Selective digestive decontamination (SDD) was introduced from the end of April 2021 in the structured protocol for VAP prevention. The SDD consisted of a tobramycin sulphate, colistin sulphate and amphotericin B suspension applied in the patient oropharynx and the stomach via nasogastric tube. Three-hundred forty-eight patients were included in the study. In the 86 patients (32,9%) who received SDD the occurrence of VAP decreased by 7,7% (p = 0,192) compared to patients who did not receive SDD. Onset time of VAP, the occurrence of multidrug-resistant microorganisms AP, the length of invasive mechanical ventilation and hospital mortality were similar in patients who received and who did not receive SDD. The multivariate analysis adjusted for confounders showed that the use of SDD reduces the occurrence of VAP (HR 0,536, CI 0,338-0,851; p = 0,017) Our pre-post observational study indicates that the use of SDD in a structured protocol for VAP prevention seems to reduce the occurrence of VAP without changes in the incidence of multidrug-resistant bacteria in COVID19 patients. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| العلاقة: | info:eu-repo/semantics/altIdentifier/wos/WOS:000939097800001; volume:12; issue:4; firstpage:1; lastpage:9; journal:JOURNAL OF CLINICAL MEDICINE; https://hdl.handle.net/11380/1296908Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85149113342 |
| DOI: | 10.3390/jcm12041432 |
| الإتاحة: | https://doi.org/10.3390/jcm12041432Test https://hdl.handle.net/11380/1296908Test |
| حقوق: | info:eu-repo/semantics/openAccess |
| رقم الانضمام: | edsbas.F586CC03 |
| قاعدة البيانات: | BASE |
| DOI: | 10.3390/jcm12041432 |
|---|